» Articles » PMID: 38672758

The End Justifies the Means: Chagas Disease from a Perspective of the Host- Interaction

Overview
Journal Life (Basel)
Specialty Biology
Date 2024 Apr 27
PMID 38672758
Authors
Affiliations
Soon will be listed here.
Abstract

The neglected Chagas disease (CD) is caused by the protozoan parasite . Despite CD dispersion throughout the world, it prevails in tropical areas affecting mainly poor communities, causing devastating health, social and economic consequences. Clinically, CD is marked by a mildly symptomatic acute phase, and a chronic phase characterized by cardiac and/or digestive complications. Current treatment for CD relies on medications with strong side effects and reduced effectiveness. The complex interaction between the parasite and the host outlines the etiology and progression of CD. The unique characteristics and high adaptability of , its mechanisms of persistence, and evasion of the immune system seem to influence the course of the disease. Despite the efforts to uncover the pathology of CD, there are many gaps in understanding how it is established and reaches chronicity. Also, the lack of effective treatments and protective vaccines constitute challenges for public health. Here, we explain the background in which CD is established, from the peculiarities of molecular biology to the development of the host's immune response leading to the pathophysiology of CD. We also discuss the state of the art of treatments for CD and current challenges in basic and applied science.

Citing Articles

Zinc from an Essential Element to an Antiparasitic Therapeutic Agent.

Navarro M, Daniel L, Colina-Vegas L, Visbal G ACS Omega. 2025; 10(3):2393-2414.

PMID: 39895759 PMC: 11780429. DOI: 10.1021/acsomega.4c07331.


Trends in Microbiology 2024.

Rampelotto P, Kolar M Life (Basel). 2025; 15(1.

PMID: 39860005 PMC: 11766640. DOI: 10.3390/life15010065.


Network Analysis of Pathogenesis Markers in Murine Chagas Disease Under Antimicrobial Treatment.

Dias N, Dias M, Ribeiro A, Gomes N, Moraes A, Wesley M Microorganisms. 2024; 12(11).

PMID: 39597721 PMC: 11596328. DOI: 10.3390/microorganisms12112332.

References
1.
Jung B, Kim E, Song H, Chai J, Seo K . Immunogenicity of Exosomes from Dendritic Cells Stimulated with Toxoplasma gondii Lysates in Ocularly Immunized Mice. Korean J Parasitol. 2020; 58(2):185-189. PMC: 7231829. DOI: 10.3347/kjp.2020.58.2.185. View

2.
Rosenberg C, Martin D, Tarleton R . CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J Immunol. 2010; 185(1):560-8. PMC: 3784248. DOI: 10.4049/jimmunol.1000432. View

3.
Paiva C, Lannes-Vieira J, Gattass C . Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge. Exp Parasitol. 1999; 91(1):7-19. DOI: 10.1006/expr.1999.4356. View

4.
Acosta Rodriguez E, Araujo Furlan C, Fiocca Vernengo F, Montes C, Gruppi A . Understanding CD8 T Cell Immunity to Trypanosoma cruzi and How to Improve It. Trends Parasitol. 2019; 35(11):899-917. PMC: 6815727. DOI: 10.1016/j.pt.2019.08.006. View

5.
Tonelli R, Giordano R, Barbu E, Torrecilhas A, Kobayashi G, Langley R . Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo. PLoS Negl Trop Dis. 2010; 4(11):e864. PMC: 2970537. DOI: 10.1371/journal.pntd.0000864. View